These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 33588862)
41. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma. Huang G; Zhang J; Gong L; Huang Y; Liu D BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809 [TBL] [Abstract][Full Text] [Related]
42. Immune signature of T follicular helper cells predicts clinical prognostic and therapeutic impact in lung squamous cell carcinoma. Xu F; Zhang H; Chen J; Lin L; Chen Y Int Immunopharmacol; 2020 Apr; 81():105932. PubMed ID: 31836430 [TBL] [Abstract][Full Text] [Related]
43. Development and validation of a novel survival model for head and neck squamous cell carcinoma based on autophagy-related genes. Ren Z; Zhang L; Ding W; Luo Y; Shi Z; Shrestha B; Kan X; Zhang Z; Ding J; He H; Hu X Genomics; 2021 Jan; 113(1 Pt 2):1166-1175. PubMed ID: 33227411 [TBL] [Abstract][Full Text] [Related]
44. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma. Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900 [TBL] [Abstract][Full Text] [Related]
45. Cancer Stemness-Based Prognostic Immune-Related Gene Signatures in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma. Li N; Li Y; Zheng P; Zhan X Front Endocrinol (Lausanne); 2021; 12():755805. PubMed ID: 34745015 [TBL] [Abstract][Full Text] [Related]
46. Identification and validation of a CCL18-related signature for prediction of overall survival in patients with uveal melanoma. Yang B; Fan Y; Chen M; Tang L; Tang X; Li H; Gu A; Liang R; Wu Y Exp Eye Res; 2023 May; 230():109448. PubMed ID: 36967081 [TBL] [Abstract][Full Text] [Related]
47. Construction and analysis of a competing endogenous RNA network to reveal potential prognostic biomarkers for Oral Floor Squamous Cell Carcinoma. Zhang W; Xu S; Shi L; Zhu Z; Xie X PLoS One; 2020; 15(9):e0238420. PubMed ID: 32931492 [TBL] [Abstract][Full Text] [Related]
48. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs. Zhao Q; Fan C BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053 [TBL] [Abstract][Full Text] [Related]
49. 29 immune-related genes pairs signature predict the prognosis of cervical cancer patients. Nie H; Bu F; Xu J; Li T; Huang J Sci Rep; 2020 Aug; 10(1):14152. PubMed ID: 32843657 [TBL] [Abstract][Full Text] [Related]
50. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses. Guo H; Li C; Su X; Huang X Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843 [No Abstract] [Full Text] [Related]
51. Novel Prognostic Biomarkers for Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (CESC) Patients via Analysis of Competing Endogenous RNA (ceRNA) Network. Dong Y; Wen W; Yuan T; Liu L; Li X Dis Markers; 2023; 2023():1766080. PubMed ID: 36817087 [TBL] [Abstract][Full Text] [Related]
52. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma. Wu P; Zheng Y; Wang Y; Wang Y; Liang N J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329 [TBL] [Abstract][Full Text] [Related]
53. Identifying prognostic biomarkers in oral squamous cell carcinoma: an integrated single-cell and bulk RNA sequencing study on mitophagy-related genes. Li M; Wei Y; Huang W; Wang C; He S; Bi S; Hu S; You L; Huang X Sci Rep; 2024 Aug; 14(1):19992. PubMed ID: 39198614 [TBL] [Abstract][Full Text] [Related]
54. A Novel Pyroptosis-Related Prognostic Signature for Cervical Squamous Cell Carcinoma. Ou T; Wei Y; Long Y; Pan X; Yao D Int J Gen Med; 2022; 15():2057-2073. PubMed ID: 35237069 [TBL] [Abstract][Full Text] [Related]
55. Construction of a Prognostic Immune Signature for Squamous-Cell Lung Cancer to Predict Survival. Chen RL; Zhou JX; Cao Y; Sun LL; Su S; Deng XJ; Lin JT; Xiao ZW; Chen ZZ; Wang SY; Lin LZ Front Immunol; 2020; 11():1933. PubMed ID: 33072067 [TBL] [Abstract][Full Text] [Related]
56. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer. Peng Y; Wang H; Huang Q; Wu J; Zhang M J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063 [TBL] [Abstract][Full Text] [Related]
57. Construction and validation of a prognostic model based on stage-associated signature genes of head and neck squamous cell carcinoma: a bioinformatics study. Chen L; Zhang X; Lin J; Wen Y; Chen Y; Chen CB Ann Transl Med; 2022 Dec; 10(24):1316. PubMed ID: 36660709 [TBL] [Abstract][Full Text] [Related]
58. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Yang L; Lu P; Yang X; Li K; Chen X; Qu S Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376 [TBL] [Abstract][Full Text] [Related]
59. A novel risk score model based on eight genes and a nomogram for predicting overall survival of patients with osteosarcoma. Wu G; Zhang M BMC Cancer; 2020 May; 20(1):456. PubMed ID: 32448271 [TBL] [Abstract][Full Text] [Related]
60. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis. Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]